WVU graduate student Josh Gross investigates RGS12 as a potential target for cocaine- and amphetamine-addiction therapeutics

West Virginia University doctoral candidate Josh Gross is investigating how RGS12 influences the brain’s response to cocaine and psychostimulants with abuse potential. Gross is conducting his research in collaboration with his mentors David Siderovski, Chair of WVU’s Physiology, Pharmacology, and Neuroscience Department, and Vince Setola, Director of WVU’s Laboratory of Neuroscience and Genetics of Substance Abuse.

Screen Shot 2018-01-24 at 11.36.02 AM

http://journals.sagepub.com/doi/full/10.1177/0269881117742100

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s